Found 26 matching trials
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029) PHASE2 The purpose of this study was to determine the appropriate dosing regimen o...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED) PHASE3 A clinical study to determine the efficacy and safety of MK0869 in the trea...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061) PHASE3 A clinical study to determine the efficacy and safety of an Treatment of MK...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED) PHASE3 A clinical study to determine the efficacy and safety of an investigational...
Show More Location
Multiple Locations
Learn More & Join Trial
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED) PHASE3 The purpose of this study is to assess the safety and efficacy of 2 doses o...
Show More Location
Multiple Locations
Learn More & Join Trial
Medications Development for the Treatment of Cannabis Related Disorders PHASE1 The primary objective of this application is to test the neurobehavioral me...
Show More Location
Clinical Pharmacological Research Unit (CPRU), University of Virginia School of Medicine
Learn More & Join Trial
Effects of Substance P Antagonists on Adrenal Secretion PHASE4 Data from the literature and previous in vitro research conducted in the in...
Show More Location
Rouen Clinical research Centre (CIC 0204)
Learn More & Join Trial
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting PHASE3 NETU-10-29 is a clinical study assessing safety of netupitant and palonoset...
Show More Location
Northwest Alabama Cancer Center PC
Learn More & Join Trial
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208) PHASE3 This study will compare the safety and efficacy of a three-day oral aprepit...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED) PHASE3 A clinical study to determine the efficacy and safety of an investigational...
Show More Location
Multiple Locations
Learn More & Join Trial